<DOC>
	<DOCNO>NCT01448421</DOCNO>
	<brief_summary>This research study use SMT Embolic Deflection Device involve patient aortic stenosis ( disease aortic valve ) , treat Transcatheter Aortic Valve Replacement ( TAVR ) . The TAVR procedure consist replace diseased aortic valve new artificial valve . The new valve put place use long , thin tube call catheter insert small incision ( cut ) patient 's groin thread his/her artery heart . During TAVR procedure , risk abnormal particle ( call embolism ) could break inside artery travel brain . The embolism could make clump blood ( clot ) , air , part body tissue , part medical device . If embolism carry blood brain , could cause stroke neurological ( brain ) problem . A stroke happen blood flow part brain block , cause brain cell die . The SMT Embolic Deflection Device develop prevent embolism go brain cause stroke brain damage . The device wire mesh filter cover vessel carry blood brain , deflect blood clot material away patient 's brain towards low body , less likely cause harm .</brief_summary>
	<brief_title>SMT Embolic Deflection CE Mark Trial DEFLECT I</brief_title>
	<detailed_description />
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<criteria>1 . The patient must ≥18 year age . 2 . Patient meet indication TAVR procedure . 3 . The patient willing comply protocolspecified followup evaluation . 4 . The patient , legally authorize representative , informed nature study , agree provision provide write informed consent , approve appropriate Medical Ethics Committee ( EC ) Institutional Review Board ( IRB ) . 1 . Patients undergo TAVR via transaxillary , subclavian , direct aortic route 2 . Pregnant nursing subject plan pregnancy period 1 year follow index procedure . Female subject childbearing potential must negative pregnancy test do within 7 day prior index procedure per site standard test . 3 . Patients know diagnosis acute myocardial infarction ( AMI ) within 72 hour precede index procedure ( accord definition ) AMI &gt; 72 hour precede index procedure , CK CKMB return within normal limit time procedure . 4 . Patients currently experience clinical symptom consistent new onset AMI , nitrateunresponsive prolong chest pain . 5 . Patients impaired renal function ( estimate Glomerular Filtration Rate [ eGFR ] &lt; 30 , calculate serum creatinine CockcroftGault formula ) 6 . Patients platelet count &lt; 100.000 cells/mm³ &gt; 700.000 cells/mm³ WBC &lt; 3000 cells/mm³ within 7 day prior index procedure . 7 . Patients history bleed diathesis coagulopathy patient antiplatelet and/or anticoagulant therapy contraindicate , refuse transfusion . 8 . Patients receive organ transplant wait list organ transplant . 9 . Patients know medical illness know history substance abuse may cause noncompliance protocol , confound data interpretation associate life expectancy le one year . 10 . Patients know hypersensitivity contraindication aspirin , heparin/bivalirudin , clopidogrel/ticlopidine , nitinol , stainless steel alloy , and/or contrast sensitivity adequately premedicated . 11 . Patients history stroke transient ischemic attack ( TIA ) within prior 6 month . 12 . Patients active peptic ulcer history upper gastrointestinal ( GI ) bleeding within prior 6 month . 13 . Patients present cardiogenic shock . 14 . Patients severe peripheral arterial disease preclude 9Fr sheath vascular access . 15 . Patients document friable mobile atherosclerotic plaque aortic arch . 16 . Patients contraindication cerebral MRI . 17 . Patients plan treatment investigational device procedure study period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>TAVR</keyword>
</DOC>